Viewing Study NCT01674595


Ignite Creation Date: 2025-12-24 @ 2:14 PM
Ignite Modification Date: 2025-12-25 @ 2:18 PM
Study NCT ID: NCT01674595
Status: COMPLETED
Last Update Posted: 2013-04-30
First Post: 2012-08-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Open Trial to Assess the Tolerability of AVANZ Olive Immunotherapy
Sponsor: ALK-Abelló A/S
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module